...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>International journal of endocrinology >Comprehensive Literature Review: Recent Advances in Diagnosing and Managing Patients with Poorly Differentiated Thyroid Carcinoma
【24h】

Comprehensive Literature Review: Recent Advances in Diagnosing and Managing Patients with Poorly Differentiated Thyroid Carcinoma

机译：综合文献评论：分化差的甲状腺癌患者的诊治新进展

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Poorly differentiated thyroid carcinomas are a rare form of thyroid carcinomas; they display an intermediate behavior between well-differentiated and anaplastic thyroid carcinomas. PDTCs are more aggressive than the well-differentiated, but less aggressive than the undifferentiated or anaplastic, forms. No clinical features can accurately diagnose poorly differentiated thyroid carcinomas. Thus, the results of histocytology, immunohistochemistry, and molecular genetics tests aid in diagnosis. Given the aggressiveness of poorly differentiated thyroid carcinomas and the poor survival rates in patients who undergo surgery alone, a multimodality treatment approach is required. We conducted a comprehensive review of the current diagnostic and therapeutic tools in the management of patients with poorly differentiated thyroid carcinomas.
机译：分化差的甲状腺癌是甲状腺癌的一种罕见形式。它们显示出分化良好的甲状腺癌和间变性甲状腺癌之间的中间行为。 PDTC比高分化形式更具侵略性，但与未分化或间变性形式相比，侵袭性较小。没有临床特征可以准确诊断低分化甲状腺癌。因此，组织细胞学，免疫组织化学和分子遗传学检测的结果有助于诊断。鉴于低分化甲状腺癌的侵袭性和仅接受手术的患者生存率低，因此需要一种多模式治疗方法。我们对低分化甲状腺癌患者的治疗中的当前诊断和治疗工具进行了全面回顾。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号